Download PDF
Thromb Haemost 1994; 71(03): 284-285
DOI: 10.1055/s-0038-1642431
Original Article
Schattauer GmbH Stuttgart

Effects of Low Intensity Antithrombotic Regimes on the Haemoglobin Level

T W Meade
The MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, The Medical College of St Bartholomew's Hospital, London, UK
,
D J Howarth
The MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, The Medical College of St Bartholomew's Hospital, London, UK
,
P J Brennan
The MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, The Medical College of St Bartholomew's Hospital, London, UK
› Author Affiliations
Further Information

Publication History

Received: 10 August 1993

Accepted after revision 10 October 1993

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The effects on the haemoglobin level of low dose aspirin and of low intensity oral anticoagulation with warfarin separately and in combination have been established in men aged between 45 and 69 at high risk of ischaemic heart disease. The findings confirm that combined treatment with warfarin and aspirin (WA) leads to a clear excess of minor bleeding episodes over warfarin alone (W) or aspirin alone (A). Each separate treatment on its own (either W or A) leads to an increase in these episodes compared with those on placebo (P) treatment. However, neither combined treatment (WA) nor the separate treatments (W or A) cause a fall in haemoglobin levels over a period of up to two years.

 

  • References

  • 1 Meade TW. Low intensity oral anticoagulation. In: Thrombosis and its Management Poller L, Thomson JM. (Eds). Churchill Livingstone; UK: 1993: 84-97
  • 2 Poller L, McKernan A, Thomson JM. et al. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Br Med J 1987; 295: 1309-12
    CrossrefPubMedGoogle Scholar
  • 3 Bern MM, Lokich JJ, Wallach SR. et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: A randomized prospective trial.. Ann Intern Med 1990; 112: 423-8
    CrossrefPubMedGoogle Scholar
  • 4 The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-30
    CrossrefPubMedGoogle Scholar
  • 5 The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325: 1261-6
    CrossrefPubMedGoogle Scholar
  • 6 The SALT Collaborative Group. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991; 338: 1345-9
    CrossrefPubMedGoogle Scholar
  • 7 Juul-Moller S, Edvardsson N, Jahnmatz B. et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 1992; 340: 1421-5
    CrossrefPubMedGoogle Scholar
  • 8 ISIS-2 Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1986; 2: 349-60
    PubMedGoogle Scholar
  • 9 Turpie AG G, Gent M, Laupacis A. et al. A comparison of aspirin with placebo in patients treated with warfarin following heart valve replacement. N Engl J Med 1993; 329: 524-9
    CrossrefPubMedGoogle Scholar
  • 10 Meade TW, Roderick PJ, Brennan PJ, Wilkes HC, Kelleher CC. Extracranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation. Thrombosis and Haemostasis 1992; 68: 1-6
    Article in Thieme ConnectPubMedGoogle Scholar